Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Seres Therapeutics Inc 101 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 USA

www.serestherapeutics.com Employees: 160 P: 617-945-9626

Description:

Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 133,233
Enterprise Value, $K 106,803
Shares Outstanding, K 170,200
Annual Sales, $ 126,330 K
Annual Net Income, $ -113,720 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -40,130 K
EBIT, $ -77,010 K
EBITDA, $ -69,860 K
60-Month Beta 2.03
% of Insider Shareholders 5.10%
% of Institutional Shareholders 59.34%
Float, K 161,520
% Float 94.90%
Short Volume Ratio 0.65

Growth:

1-Year Return -43.46%
3-Year Return -88.79%
5-Year Return -78.79%
5-Year Revenue Growth 346.87%
5-Year Earnings Growth 63.37%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.22 on 08/13/24
Next Earnings Date 11/07/24
Earnings Per Share ttm -0.60
EPS Growth vs. Prev Qtr 18.52%
EPS Growth vs. Prev Year -161.11%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MCRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -46.67%
Profit Margin % -90.02%
Debt/Equity -1.71
Price/Sales 1.04
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.40
Interest Coverage -7.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar